Clinical Trials Browser

Phase 2 × Breast Neoplasms × Fluorodeoxyglucose F18 × Clear all

NCT07285993 2026-02-13

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT04316117 2026-01-26

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Phase 2 Active not recruiting

Breast Neoplasms

NCT02317783 2024-11-20

Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

Phase 2 Terminated

15 enrolled 6 charts

Breast Neoplasms

NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Phase 2 Enrolling by invitation

BreastEndocrineLymphoidNETSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT00602043 2020-02-19

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

Phase 2 Completed

20 enrolled 6 charts

Breast Neoplasms

NCT02455453 2020-01-14

Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography

Phase 2 Completed

47 enrolled 8 charts

Breast Neoplasms

NCT02599194 2019-01-03

18F-FSPG PET/CT for Cancer Patients on Therapy

Phase 2 Completed

7 enrolled 6 charts

BreastGenitourinaryLymphoidOther solid neoplasmThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Lymphoma, B-Cell, Triple Negative Breast Neoplasms